Channel Estimation for Cyclic-Prefixed Single-Carrier Broadband Wireless Systems

This paper presents a new block iterative/adaptive frequency-domain channel estimation scheme, in which a channel frequency response (CFR) is estimated iteratively by the proposed weighted element-wise block adaptive frequency-domain channel estimation (WEB-CE) scheme using the soft information obtained by a soft-input soft-output (SISO) decoder. In the WEB-CE, an equalizer coefficient is calculated by minimizing a weighted conditional squared-norm of the a posteriori error vector with respect to its correction term. Simulation results verify the superiority of the WEB-CE in a time-varying typical urban (TU) channel

Physical Layer Time Interleaving for the ATSC 3.0 System

"(c) 2016 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other users, including reprinting/ republishing this material for advertising or promotional purposes, creating new collective works for resale or redistribution to servers or lists, or reuse of any copyrighted components of this work in other works.")This paper presents optimized time interleaving which has been adopted for the Advanced Television System Committee 3.0 system as a physical layer tool to mitigate the effects of burst errors. The adopted time interleaver (TI) is very flexible and can have different configurations according to the number of physical layer pipes (PLPs) and service type, i.e., fixed, portable, and mobile. Notably, for single-PLP mode a sheer convolutional TI (CTI) is used, whereas for the multiple-PLP mode a hybrid TI (HTI) composed of cell interleaver, twisted block interleaver, and a convolutional delay-line is used. Optionally, the CTI and the HTI can be used in conjunction with extended time interleaving and a cell interleaver (only for HTI) to further improve robustness over long burst error lengths at the expense of latency.Klenner, P.; Baek, J.; Loghin, NS.; Gómez Barquero, D.; Ko, W. (2016). Physical Layer Time Interleaving for the ATSC 3.0 System. IEEE Transactions on Broadcasting. 62(1):253-262. doi:10.1109/TBC.2015.2505410S25326262

Effects of Combined Therapy with Ezetimibe Plus Simvastatin After Drug-Eluting Stent Implantation in a Porcine Coronary Restenosis Model

The aim of this study was to examine the anti-proliferative and anti-inflammatory effects of ezetimibe/simvastatin (E/S) after drug-eluting stent (DES) implantation in a porcine coronary restenosis model. Pigs were randomized into two groups in which the coronary arteries (23 pigs) had DES. Stents were deployed with oversizing (stent/artery ratio 1.3:1) in porcine coronary arteries. Fifteen pigs were taken 10/20 mg of E/S and eight pigs were not taken E/S. Histopathologic analysis was assessed at 28 days after stenting. In neointima, most inflammatory cells were lymphohistiocytes. Lymphohistiocyte count was not different between two groups (337±227 vs. 443±366 cells, P=0.292), but neointima area was significantly smaller (1.00±0.49 mm2 vs. 1.69±0.98 mm2, P=0.021) and percent area stenosis was significantly lower (23.3±10% vs. 39±19%, P=0.007) in E/S group compared with control group. There were no significant differences in fibrin score (1.99±0.79 vs. 1.81±0.88, P=0.49), endothelial score (1.75±0.66 vs. 1.80±0.59, P=0.79), and the percent of endothelium covered lumen (43±21% vs. 45±21%, P=0.84) between E/S group and control group. Combined therapy with ezetimibe and simvastatin inhibits neointimal hyperplasia, but does not inhibit inflammatory infiltration and arterial healing after DES implantation in a porcine coronary restenosis model

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment

Among cancer cells, indoleamine 2, 3-dioxygenase1 (IDO1) activity has been implicated in improving the proliferation and growth of cancer cells and suppressing immune cell activity. IDO1 is also responsible for the catabolism of tryptophan to kynurenine. Depletion of tryptophan and an increase in kynurenine exert important immunosuppressive functions by activating regulatory T cells and suppressing CD8+ T and natural killer (NK) cells. In this study, we compared the anti-tumor effects of YH29407, the best-in-class IDO1 inhibitor with improved pharmacodynamics and pharmacokinetics, with first and second-generation IDO1 inhibitors (epacadostat and BMS-986205, respectively). YH29407 treatment alone and anti-PD-1 (aPD-1) combination treatment induced significant tumor suppression compared with competing drugs. In particular, combination treatment showed the best anti-tumor effects, with most tumors reduced and complete responses. Our observations suggest that improved anti-tumor effects were caused by an increase in T cell infiltration and activity after YH29407 treatment. Notably, an immune depletion assay confirmed that YH29407 is closely related to CD8+ T cells. RNA-seq results showed that treatment with YH29407 increased the expression of genes involved in T cell function and antigen presentation in tumors expressing ZAP70, LCK, NFATC2, B2M, and MYD88 genes. Our results suggest that an IDO1 inhibitor, YH29407, has enhanced PK/PD compared to previous IDO1 inhibitors by causing a change in the population of CD8+ T cells including infiltrating T cells into the tumor. Ultimately, YH29407 overcame the limitations of the competing drugs and displayed potential as an immunotherapy strategy in combination with aPD-1

An In-situ XPS study of non-evaporable ZrVFe getter material

To investigate the temperature dependence of a synthesized Zr57V36Fe7 non evaporable vacuum getter material, the in-situ temperature x-ray photoelectron spectroscopy (in-situ XPS) were performed in a UHV chamber equipped with a programmable ceramic sample heating system. The surface and bulk composition of Zr, V, and Ti was determined in the as-received state and after in-situ heating from 50℃ to 600℃ at 50℃per step. The peak fitting results for O 1s, C 1s, Zr 3d, V 2p, and Fe 2p high resolution spectra were acquired and the chemical state of the elements were then characterized as a function of heating temperature. In-situ XPS investigations showed that oxide reduction proceeds via the formation of sub-oxides with the simultaneous formation of carbides in the region near the surface. The activation temperature for completion of the Zr57V36Fe7 alloy, which approximates the XPS peaks changed from oxide to metallic state(20 % of the oxide peak), was determined around 480℃. The findings suggest that the in-situ temperature XPS technique is a useful analytical tool for evaluating activation characteristics of NEG materials

Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis

In locally advanced pancreatic cancer (LAPC), stereotactic body radiation therapy (SBRT) has been applied as an alternative to concurrent chemoradiotherapy (CCRT); however, direct comparative evidence between these two modalities is scarce. The aim of this study was to compare the clinical outcomes of SBRT with CCRT for LAPC. We retrospectively reviewed the medical records of patients with LAPC who received SBRT (n = 95) or CCRT (n = 66) with a concurrent 5-FU-based regimen between January 2008 and July 2016. The clinical outcomes of freedom from local progression (FFLP), progression-free survival (PFS), overall survival (OS), and toxicities were analyzed before and after propensity score (PS) matching. After a median follow-up duration of 15.5 months (range, 2.3–64.5), the median OS, PFS, and FFLP of the unmatched patients were 17.3 months, 11 months, and 19.6 months, respectively. After PS matching, there were no significant differences between the SBRT and CCRT groups in terms of the 1-year rates of OS (66.7% vs. 80%, p = 0.455), PFS (40.0% vs. 54.2%, p = 0.123), and FFLP (77.2% and 87.1%, p = 0.691). Our results suggest SBRT could be a feasible alternative to CCRT in treating patients with LAPC